Filing Details
- Accession Number:
- 0001883850-22-000054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-08 16:12:30
- Reporting Period:
- 2022-08-04
- Accepted Time:
- 2022-08-08 16:12:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187443 | F Arthur Ryan | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-08-04 | 2,500 | $0.00 | 19,682 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2022-08-04 | 3,613 | $482.68 | 23,295 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-04 | 4,887 | $620.85 | 18,408 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-08-04 | 4,361 | $374.12 | 22,769 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-04 | 4,156 | $621.54 | 18,613 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-08-04 | 2,479 | $380.95 | 21,092 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-04 | 1,410 | $622.06 | 19,682 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-08-04 | 4,361 | $0.00 | 4,361 | $374.12 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-08-04 | 2,479 | $0.00 | 2,479 | $380.95 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-08-04 | 3,613 | $0.00 | 3,613 | $482.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-01-02 | No | 4 | M | Direct | |
| 0 | 2028-01-02 | No | 4 | M | Direct | |
| 0 | 2031-01-04 | No | 4 | M | Direct |
Footnotes
- Represents volume-weighted average price of sales of 4,887 shares of Company stock on August 4, 2022 at prices ranging from $620.16 to $620.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
- Represents volume-weighted average price of sales of 4,156 shares of Company stock on August 4, 2022 at prices ranging from $621.00 to $621.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
- Represents volume-weighted average price of sales of 1,410 shares of Company stock on August 4, 2022 at prices ranging from $622.00 to $622.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
- On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
